MB
Manish Bhagwandas Ved
About Manish Bhagwandas Ved
Data last updated:
Manish Bhagwandas Ved is a Director at Vaishali Pharma Limited (since 2019). The company operates in Pharma. Vaishali Pharma Limited reported revenue of ₹102 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Vaishali Pharma Limited L52310MH2008PLC181632 | Director | 31 Dec 2019 | 2008 | ₹102 Cr (FY 2025) | Active |
Board colleagues of Manish Bhagwandas Ved
| Name | DIN | Company | Designation |
|---|---|---|---|
| Atul Arvind Vasani | 02107085 | Vaishali Pharma Limited | Managing Director |
| Dewansh Ajay Vasani | 08111804 | Vaishali Pharma Limited | Director |
| Dewansh Ajay Vasani | Vaishali Pharma Limited | Cfo | |
| Hemant Damodar Pathak | Vaishali Pharma Limited | Ceo | |
| Jagruti Atul Vasani | 02107094 | Vaishali Pharma Limited | Whole-Time Director |
| Pratik Vikram Jakhelia | 07726752 | Vaishali Pharma Limited | Director |
| Vishwa Bipinbhai Mekhia | Vaishali Pharma Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manish Bhagwandas Ved
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manish Bhagwandas Ved
Manish Bhagwandas Ved currently holds 1 directorship: Vaishali Pharma Limited (Director, since 31 Dec 2019, revenue ₹102 Cr (FY 2025)).
Manish Bhagwandas Ved was first appointed on 31 Dec 2019 as Director at Vaishali Pharma Limited.
The current boards of Manish Bhagwandas Ved's companies include Atul Arvind Vasani (Vaishali Pharma Limited), Dewansh Ajay Vasani (Vaishali Pharma Limited), Dewansh Ajay Vasani (Vaishali Pharma Limited), Hemant Damodar Pathak (Vaishali Pharma Limited), Jagruti Atul Vasani (Vaishali Pharma Limited), Pratik Vikram Jakhelia (Vaishali Pharma Limited), among others.